Market Overview:
The global fetal alcohol spectrum disorder treatment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of fetal alcohol spectrum disorder, rising awareness about the condition, and growing demand for effective treatments. Based on type, the global fetal alcohol spectrum disorder treatment market is segmented into antidepressants, stimulants, neuroleptics, and antianxiety drugs. Antidepressants are expected to account for the largest share of this market in 2018 owing to their high efficacy in treating symptoms associated with fetal alcohol spectrum disorder. Stimulants are also expected to witness significant growth during the forecast period due to their ability to improve cognitive function and reduce hyperactivity in patients with fetal alcohol spectrum disorder. Based on application, the global fetal alcohol syndrome treatment market is segmented into hospital pharmacies, retail pharmacies, drug stores,, and e-commerce platforms. Hospital pharmacies are expected account for a major share of this market in 2018 as they offer specialized treatments for patients with Fetal Alcohol Spectrum Disorder (FASD).
Product Definition:
Fetal Alcohol Spectrum Disorder Treatment is important because it can help children who have been affected by their mother's drinking while pregnant. The treatment can help improve the child's life and development.
Antidepressants:
Antidepressants are used to treat a wide range of mental disorders, including major depression, anxiety disorder (such as panic disorder and phobias), bipolar disorder (manic-depression), multiple sclerosis, stroke-induced depression, and others. The global antidepressants market is driven by factors such as the growing prevalence of mental disorders coupled with increasing awareness about their treatment options.
Stimulants:
Stimulants are drugs that increase the activity of the central nervous system. Stimulants are used in treating FASD as they help to improve motor skills and reduce social withdrawal in patients suffering from fetal alcohol spectrum disorder (FASD).
Stimulant medications include methylphenidate, amphetamine, dextroamphetamine, lisdexamfetamine, and cathinone.
Application Insights:
Based on application, the market is segmented into hospital pharmacies, retail pharmacies, drug stores and e-commerce. The hospital pharmacies held the largest share in 2017 as a result of factors such as high usage rates of anticonvulsants and antidepressants among others in hospitals. Moreover, growing awareness about FASD treatment coupled with rising adoption of these products by pregnant women is expected to drive growth over the forecast period.
The drug store segment is anticipated to witness lucrative growth during the study period owing to increasing cases of mental disorders during pregnancy coupled with rising adoption rate for antianxiety drugs among other pharmaceutical products for treating mental disorders during pregnancy.
Regional Analysis:
North America accounted for the largest share of global market in 2017. The high prevalence of Fetal Alcohol Syndrome (FAS) and its associated disorders, growing awareness about mental health, and availability of treatment are some factors contributing to the large share. According to data published by National Institute on Alcohol Abuse and Alcoholism (NIAAA), around 40 million Americans have consumed alcohol during pregnancy; 1 in 5 women drinkers had a baby with fetal alcohol syndrome (FAS). In addition, easy access to healthcare services is also expected to drive regional growth over the forecast period.
Asia Pacific is estimated to be one of the fastest-growing regions during the forecast period owing to rising disposable income levels among people suffering from FASD symptoms such as behavioral problems, learning disabilities, sleep apnea etc., which can be treated only through medication prescribed by a psychiatrist or neurologist.
Growth Factors:
- Increasing awareness about fetal alcohol spectrum disorder (FASD) and its potential risks is likely to drive the growth of the fetal alcohol spectrum disorder treatment market.
- Rising incidence of FASD is another key factor that is expected to fuel the demand for fetal alcohol spectrum disorder treatment products and services in the coming years.
- The increasing number of pregnant women who are consuming alcohol is also anticipated to boost the growth of this market in near future.
- Growing research and development activities for new diagnostic tools and treatments for FASD are expected to create lucrative opportunities for players operating in this market over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fetal Alcohol Spectrum Disorder Treatment Market Research Report
By Type
Antidepressants, Stimulants, Neuroleptics, Antianxiety Drugs
By Application
Hospital Pharmacies, Retail Pharmacies, Drug Store, E-Commerce
By Companies
Forest Laboratories, Wyeth, Amneal Pharms, GlaxoSmithKline, Eli Lilly, Schering-Plough, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Fetal Alcohol Spectrum Disorder Treatment Market Report Segments:
The global Fetal Alcohol Spectrum Disorder Treatment market is segmented on the basis of:
Types
Antidepressants, Stimulants, Neuroleptics, Antianxiety Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Drug Store, E-Commerce
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Forest Laboratories
- Wyeth
- Amneal Pharms
- GlaxoSmithKline
- Eli Lilly
- Schering-Plough
- Pfizer
Highlights of The Fetal Alcohol Spectrum Disorder Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antidepressants
- Stimulants
- Neuroleptics
- Antianxiety Drugs
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- E-Commerce
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fetal Alcohol Spectrum Disorder Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fetal alcohol spectrum disorder (FASD) is a condition that occurs when a pregnant woman drinks alcohol and her baby has problems with development. FASD can cause problems with learning, memory, attention, behavior, and coordination. Treatment for FASD includes counseling and therapy to help the child learn how to cope with their symptoms.
Some of the major companies in the fetal alcohol spectrum disorder treatment market are Forest Laboratories, Wyeth, Amneal Pharms, GlaxoSmithKline, Eli Lilly, Schering-Plough, Pfizer.
The fetal alcohol spectrum disorder treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fetal Alcohol Spectrum Disorder Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fetal Alcohol Spectrum Disorder Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fetal Alcohol Spectrum Disorder Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fetal Alcohol Spectrum Disorder Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fetal Alcohol Spectrum Disorder Treatment Market Size & Forecast, 2018-2028
4.5.1 Fetal Alcohol Spectrum Disorder Treatment Market Size and Y-o-Y Growth
4.5.2 Fetal Alcohol Spectrum Disorder Treatment Market Absolute $ Opportunity
Chapter 5 Global Fetal Alcohol Spectrum Disorder Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Type
5.2.1 Antidepressants
5.2.2 Stimulants
5.2.3 Neuroleptics
5.2.4 Antianxiety Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Fetal Alcohol Spectrum Disorder Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Drug Store
6.2.4 E-Commerce
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fetal Alcohol Spectrum Disorder Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Fetal Alcohol Spectrum Disorder Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Type
9.6.1 Antidepressants
9.6.2 Stimulants
9.6.3 Neuroleptics
9.6.4 Antianxiety Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Drug Store
9.10.4 E-Commerce
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Fetal Alcohol Spectrum Disorder Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Type
10.6.1 Antidepressants
10.6.2 Stimulants
10.6.3 Neuroleptics
10.6.4 Antianxiety Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Drug Store
10.10.4 E-Commerce
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Fetal Alcohol Spectrum Disorder Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Type
11.6.1 Antidepressants
11.6.2 Stimulants
11.6.3 Neuroleptics
11.6.4 Antianxiety Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Drug Store
11.10.4 E-Commerce
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Fetal Alcohol Spectrum Disorder Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Type
12.6.1 Antidepressants
12.6.2 Stimulants
12.6.3 Neuroleptics
12.6.4 Antianxiety Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Drug Store
12.10.4 E-Commerce
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Fetal Alcohol Spectrum Disorder Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Type
13.6.1 Antidepressants
13.6.2 Stimulants
13.6.3 Neuroleptics
13.6.4 Antianxiety Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Fetal Alcohol Spectrum Disorder Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Drug Store
13.10.4 E-Commerce
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fetal Alcohol Spectrum Disorder Treatment Market: Competitive Dashboard
14.2 Global Fetal Alcohol Spectrum Disorder Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Forest Laboratories
14.3.2 Wyeth
14.3.3 Amneal Pharms
14.3.4 GlaxoSmithKline
14.3.5 Eli Lilly
14.3.6 Schering-Plough
14.3.7 Pfizer
